Pearson: UBS still says Buy

(CercleFinance.com) - In its daily comment, UBS says that it intends to reduce its earnings forecasts for 2024, but maintains its Buy recommendation on the share.


It also maintains its target price unchanged at 1130 pence, representing 18% upside potential.

"Earnings cut mainly reflects higher interest costs than expected in 2024. We see 4% organic growth as achievable in 2024, but note there is downside risk", UBS says.

The 2024 outlook for adjusted EBIT is c2% below the VA consensus. The forecast calls for organic growth of 3.7% against a VA consensus of 4.2% and a UBSe consensus of 4.5%. FCF in 2023 is raised to £387m from £222m in 2022, the broker adds.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.